These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7829269)

  • 41. Molecular modeling and preclinical evaluation of the humanized NR-LU-13 antibody.
    Graves SS; Goshorn SC; Stone DM; Axworthy DB; Reno JM; Bottino B; Searle S; Henry A; Pedersen J; Rees AR; Libby RT
    Clin Cancer Res; 1999 Apr; 5(4):899-908. PubMed ID: 10213227
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chimeric antibodies with anti-dextran-derived complementarity-determining regions and anti-p-azophenylarsonate-derived framework regions.
    Kao CY; Sharon J
    J Immunol; 1993 Aug; 151(4):1968-78. PubMed ID: 7688391
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chimeric (mouse/human) anti-colon cancer antibody c30.6 inhibits the growth of human colorectal cancer xenografts in scid/scid mice.
    Mount PF; Sutton VR; Li W; Burgess J; McKEnzie IF; Pietersz GA; Trapani JA
    Cancer Res; 1994 Dec; 54(23):6160-6. PubMed ID: 7954462
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders.
    Presta LG; Chen H; O'Connor SJ; Chisholm V; Meng YG; Krummen L; Winkler M; Ferrara N
    Cancer Res; 1997 Oct; 57(20):4593-9. PubMed ID: 9377574
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Three-dimensional model of the BR96 monoclonal antibody variable fragment.
    Bajorath J
    Bioconjug Chem; 1994; 5(3):213-9. PubMed ID: 7522581
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clonal analysis of a human antibody response. III. Nucleotide sequences of monoclonal IgM, IgG, and IgA to rabies virus reveal restricted V kappa gene utilization, junctional V kappa J kappa and V lambda J lambda diversity, and somatic hypermutation.
    Ikematsu W; Kobarg J; Ikematsu H; Ichiyoshi Y; Casali P
    J Immunol; 1998 Sep; 161(6):2895-905. PubMed ID: 9743351
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficient generation of a reshaped human mAb specific for the alpha toxin of Clostridium perfringens.
    Tempest PR; White P; Williamson ED; Titball RW; Kelly DC; Kemp GJ; Gray PM; Forster SJ; Carr FJ; Harris WJ
    Protein Eng; 1994 Dec; 7(12):1501-7. PubMed ID: 7716162
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular analysis of IgM rheumatoid factor binding to chimeric IgG.
    Artandi SE; Canfield SM; Tao MH; Calame KL; Morrison SL; Bonagura VR
    J Immunol; 1991 Jan; 146(2):603-10. PubMed ID: 1702808
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antitumour activity of a chimeric antibody against the leucocyte antigen CD48.
    Sun H; Biggs JC; Smith GM
    Cancer Immunol Immunother; 2000 Jan; 48(10):595-602. PubMed ID: 10630312
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody.
    Goldenberg DM; Horowitz JA; Sharkey RM; Hall TC; Murthy S; Goldenberg H; Lee RE; Stein R; Siegel JA; Izon DO
    J Clin Oncol; 1991 Apr; 9(4):548-64. PubMed ID: 2066752
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Probing the interaction between a high-affinity single-chain Fv and a pyrimidine (6-4) pyrimidone photodimer by site-directed mutagenesis.
    Kobayashi H; Morioka H; Tobisawa K; Torizawa T; Kato K; Shimada I; Nikaido O; Stewart JD; Ohtsuka E
    Biochemistry; 1999 Jan; 38(2):532-9. PubMed ID: 9888792
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Expression, structure prediction and functional analysis of murine single-chain fragment variable antibody against human cervical cancer].
    Wang Y; Li X; Chen W
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):16-21. PubMed ID: 16495168
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Single-chain Fv with manifold N-glycans as bifunctional scaffolds for immunomolecules.
    Wang M; Lee LS; Nepomich A; Yang JD; Conover C; Whitlow M; Filpula D
    Protein Eng; 1998 Dec; 11(12):1277-83. PubMed ID: 9930678
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative biological properties of a recombinant chimeric anti-carcinoma mAb and a recombinant aglycosylated variant.
    Hand PH; Calvo B; Milenic D; Yokota T; Finch M; Snoy P; Garmestani K; Gansow O; Schlom J; Kashmiri SV
    Cancer Immunol Immunother; 1992; 35(3):165-74. PubMed ID: 1638552
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of monoclonal antibody glycosylation: comparison of expression systems and identification of terminal alpha-linked galactose.
    Sheeley DM; Merrill BM; Taylor LC
    Anal Biochem; 1997 Apr; 247(1):102-10. PubMed ID: 9126378
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Construction and expression of chimeric antibodies by a simple replacement of heavy and light chain V genes into a single cassette vector.
    Kanda H; Mori K; Koga H; Taniguchi K; Kobayashi H; Sakahara H; Konishi J; Endo K; Watanabe T
    Hybridoma; 1994 Oct; 13(5):359-66. PubMed ID: 7860092
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of domain deletion, glycosylation, and long IgG3 hinge on the biodistribution and serum stability properties of a humanized IgG1 immunoglobulin, hLL2, and its fragments.
    Leung SO; Qu Z; Hansen HJ; Shih LB; Wang J; Losman MJ; Goldenberg DM; Sharkey RM
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3106s-3117s. PubMed ID: 10541351
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chimeric anti-ganglioside GM2 antibody with antitumor activity.
    Nakamura K; Koike M; Shitara K; Kuwana Y; Kiuragi K; Igarashi S; Hasegawa M; Hanai N
    Cancer Res; 1994 Mar; 54(6):1511-6. PubMed ID: 8137257
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Amino acid sequence of a phosphocholine-binding antibody from an immune defective CBA/N mouse employing the T15 VH region associated with unusual DH, JH, and V kappa segments.
    Clarke SH; Kenny JJ; Sieckmann DG; Rudikoff S
    J Immunol; 1984 Mar; 132(3):1544-9. PubMed ID: 6420465
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
    Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M
    Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.